US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Disc Medicine drops on report of FDA skepticism over rare blood disorder drug
Biopharma firm Disc Medicine's Q3 net loss widens
U.S. RESEARCH ROUNDUP-Blackstone, Ford, Intel
U.S. STOCKS ON THE MOVE-RBB Bancorp, Hologic, Eversource
U.S. STOCKS ON THE MOVE-RBB Bancorp, Hologic, Eversource
U.S. STOCKS ON THE MOVE-Lockheed Martin, Truist Financial, Reddit
Disc Medicine dips after $250 mln equity offering
Brief: Disc Medicine Announces Pricing Of $250 Million Upsized Public Offering Of Common Stock
Brief: Disc Medicine Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Disc Medicine Provides Update On Hematology Portfolio
Some US drug developers jump after FDA announces recipients of national priority vouchers
Revolution, Achieve, Disc Medicine rise after FDA unveils fast-track review list
US FDA announces recipients of national priority vouchers (updated)
Disc Medicine Inc reports results for the quarter ended June 30 - Earnings Summary
Disc Medicine Q2 loss bigger than expected as costs increase
Disc Medicine Inc reports results for the quarter ended March 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Vince Holding, Northern Trust, OSI Systems
U.S. STOCKS ON THE MOVE-Guidewire, Air Products, First Community